Frank Stokes Insider Profile
4 Followers
Frank Stokes, CFO at Castle Biosciences, holds 35.18K shares in Castle Biosciences (Ticker: CSTL), holds ― shares in Exagen (Ticker: XGN). Most recently, Frank Stokes Sold ― shares of Castle Biosciences on Aug 18, 2026 for an estimated value of $741.51K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+1.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Frank Stokes
Frank Stokes's Trading History
Castle Biosciences
Aug 18, 2026
CFO
Informative Sell
741.51K
$1.16M
Exagen
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Frank Stokes's performance on stock
You May Also Like
Frank Stokes insider profile FAQ
What is the percentage of profitable transactions made by Frank Stokes?
The percentage of profitable transactions made by Frank Stokes is 50%.
What is the average return per transaction made by Frank Stokes?
The average return per transaction made by Frank Stokes is 1.00%.
What stocks does Frank Stokes hold?
Frank Stokes holds: CSTL, XGN stocks.
What was Frank Stokes’s latest transaction?
Frank Stokes latest transaction was an Informative Sell of $741.51K.
What was Frank Stokes's most profitable transaction?
Frank Stokes’s most profitable transaction was an Informative Sell of CSTL stock on December 15, 2025. The return on the trade was 15.30%.
What is Frank Stokes's role in Castle Biosciences?
Frank Stokes's role in Castle Biosciences is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.